E. Magherini
Impact in
- Oncology top 5%
- Cancer Treatment and Pharmacology
- HER2/EGFR in Cancer Research
- Colorectal Cancer Treatments and Studies
- Pancreatic and Hepatic Oncology Research
- Cancer Research top 5%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
Papers in
-
- Hepatocellular Carcinoma Treatment and Prognosis 8
- Oncology 19
- Colorectal Cancer Treatments and Studies 13
- Cancer Treatment and Pharmacology 9
- Lung Cancer Research Studies 2
- Co-authors
- Maggie C.U. CheangTorsten O. NielsenMatthieu RupinIsabelle TreilleuxCharles L. VogelCharles M. PerouJudith HughCharles Dumontet
- Journals
- Journal of Clinical Oncology (15 papers)European Journal of Cancer (3 papers)Journal of Geriatric Oncology (1 paper)Future Oncology (1 paper)Cancer Chemotherapy and Pharmacology (1 paper)
- Partner nations
- FranceBelgiumUnited Kingdom
In The Last Decade
E. Magherini
24 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 61
- Oncology 788
- Cancer Research 409
- Hepatology 118
- Dermatology 112
- Pathology and Forensic Medicine 145
Countries citing papers authored by E. Magherini
This map shows the geographic impact of E. Magherini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Magherini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Magherini more than expected).
Fields of papers citing papers by E. Magherini
This network shows the impact of papers produced by E. Magherini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Magherini. The network helps show where E. Magherini may publish in the future.
Co-authorship network
The 25 scholars most cited alongside E. Magherini, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 20 | |
| 2 | 2017 | 29 | |
| 3 | 2013 | 17 | |
| 4 | 2013 | 3 | |
| 5 | 2011 | 51 | |
| 6 | 2009 | 407 | |
| 7 | 2009 | 3 | |
| 8 | 2009 | 1 | |
| 9 | 2006 | 51 | |
| 10 | 2005 | 117 | |
| 11 | 2004 | 101 | |
| 12 | 2004 | 11 | |
| 13 | 2004 | 10 | |
| 14 | 2004 | 4 | |
| 15 | 2004 | 1 | |
| 16 | 2004 | 1 | |
| 17 | 2004 | 2 | |
| 18 | 2004 | 12 | |
| 19 | 1997 | 1 | |
| 20 | Acute myelogenous leukemia with T-cell features. | 1992 | 1 |
About E. Magherini
E. Magherini is a scholar working on Hepatology, Oncology, Dermatology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 24 papers that have together received 1.0k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (13 papers), Cancer Treatment and Pharmacology (9 papers), Hepatocellular Carcinoma Treatment and Prognosis (8 papers), Chemotherapy-related skin toxicity (4 papers), Nail Diseases and Treatments (2 papers), Cancer, Hypoxia, and Metabolism (2 papers), Cancer, Lipids, and Metabolism (2 papers) and Lung Cancer Research Studies (2 papers). The work is most often cited by research in Oncology (788 citations), Cancer Research (409 citations), Hepatology (118 citations), Dermatology (112 citations) and Pathology and Forensic Medicine (145 citations). E. Magherini has collaborated with scholars based in France, Belgium and United Kingdom. Frequent co-authors include Maggie C.U. Cheang, Torsten O. Nielsen, Matthieu Rupin, Isabelle Treilleux, Charles L. Vogel, Charles M. Perou, Judith Hugh, Charles Dumontet, John C. Reed and John Hanson. Their work appears in journals such as Journal of Clinical Oncology, European Journal of Cancer, Journal of Geriatric Oncology, Future Oncology and Cancer Chemotherapy and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.